-
1 Comment
Jiangxi Fushine Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 9.1% below its 200 day moving average.
From a valuation standpoint, the stock is 59.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.
Jiangxi Fushine Pharmaceutical Co., Ltd's total revenue sank by 21.9% to $293M since the same quarter in the previous year.
Its net income has dropped by 27.0% to $74M since the same quarter in the previous year.
Finally, its free cash flow fell by 2055.8% to $-72M since the same quarter in the previous year.
Based on the above factors, Jiangxi Fushine Pharmaceutical Co., Ltd gets an overall score of 1/5.
| ISIN | CNE1000024Z7 |
|---|---|
| Exchange | SHE |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Biotechnology |
| PE Ratio | None |
|---|---|
| Market Cap | 5B |
| Target Price | 28 |
| Beta | 0.63 |
| Dividend Yield | None |
Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products, as well as intermediates of antiviral drugs. It also provides contract research, development, and manufacturing services, as well as engages in lithium battery electrolyte additives. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is based in Jingdezhen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300497.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
